WASHINGTON, Jan. 6, 2025 /PRNewswire/ — Aya Healthcare, the largest healthcare talent software and staffing company in the U.S., has joined the Association for Advancing Physician and Provider Recruitment (AAPPR) as a Strategic Partner. Together, the organizations will work to advance the physician and provider recruitment profession by collaboratively exploring how technology can help solve workforce challenges.

AAPPR, the leading authority on physician recruitment, onboarding and retention, launched its Partner program in 2017 to create deeper connections between physician and provider recruitment professionals, the organizations they represent and the companies they rely on for technologies and services to recruit, onboard and retain talent effectively.

The program creates a direct line of communication for AAPPR members to share their challenges and identify solutions that fit recruitment professionals’ needs.

“AAPPR’s partners play a critical role in our work to help recruitment and retention leaders connect, learn and advance their careers,” said Carey Goryl, CEO of AAPPR. “We are thrilled to partner with Aya Healthcare to provide members with the resources they need to strengthen recruitment strategies through the latest technologies and innovations.”

AAPPR will work with Aya Healthcare, along with its existing partners, to support the organization’s mission to impact health care access through education, research, and the elevation of the physician and provider recruitment industry.

Aya Healthcare’s Physician and Advanced Practice Solutions deliver innovative technologies, comprehensive services and dedicated teams to build strong recruitment pipelines and effective retention strategies. Key offerings include:

DocCafe, a premier physician talent platform with access to one of the nation’s largest networks of active physicians and advanced practitioners.LotusOne, one of the industry’s most advanced vendor management systems to effectively hire and manage qualified locum providers.

Each AAPPR partnership is tailored to fulfill the company’s unique business objectives and marketing goals. Partners receive invaluable visibility with nearly 2,400 AAPPR members, including sourcing, recruiting, contracting, credentialing, certifying and onboarding professionals, who play critical roles in influencing the advancement of their health care systems. With the support of Aya Healthcare, the Partner program now includes 11 companies working together in support of AAPPR’s mission.

For more information about Aya Healthcare or the Partner program, visit www.aappr.org or email info@aappr.org. For more information about Aya Healthcare’s physician and advanced practitioner solutions, visit https://www.ayahealthcare.com/physicianrecruitment.

About The Association for Advancing Physician and Provider Recruitment
The Association for Advancing Physician and Provider Recruitment (AAPPR) is a nationally recognized leader in health care provider recruitment, onboarding, and retention. For more than 30 years, AAPPR has empowered physician and advanced practice provider recruitment leaders to transform care delivery in their communities by providing best-in-class practices, up-to-date industry knowledge, and evolving innovative approaches for hiring, onboarding, and retaining exceptional clinical talent. To learn more or to become an organizational member of AAPPR, please visit https://aappr.org/join-now.

About Aya Healthcare

Aya Healthcare is the largest healthcare talent software and staffing company in the United States. Aya operates the world’s largest digital staffing platform delivering every component of healthcare-focused labor services, including locum tenens, travel nursing and allied health, per diem, permanent staff hiring, interim leadership and non-clinical professionals. Aya’s software suite, which includes physician and advanced practice solutions, vendor management, float pool technology and MSP services, provides healthcare organizations greater efficiencies, superior operating results and reduced labor costs. While technology drives efficiency and scale, Aya’s 6,000+ global employees power the company to deliver unparalleled accountability and exceptional experiences for clients and clinicians. Aya’s company culture is rooted in giving back and supports organizations around food security, education, healthcare, safe shelter and equity. To learn more about Aya Healthcare, visit www.ayahealthcare.com.

View original content:https://www.prnewswire.com/news-releases/aya-healthcare-and-aappr-partner-to-advance-physician-and-provider-recruitment-through-technology-302341896.html

SOURCE Association for Advancing Physician and Provider Recruitment

MEMS Sensors

New WeWALK Smart Cane 2 enables “unlimited mobility for visually impaired people” utilizing TDK sensor technologyIMU motion sensors enable highly accurate navigation while operating at ultra-low powerMEMS microphones accurately capture voice commands while consuming very little powerUltrasonic time-of-flight sensors enable real-time presence detection and obstacle avoidanceTDK offers a WeWALK Smart Cane 2 giveaway at its CES 2025 booth #15815*

SAN JOSE, Calif., Jan. 6, 2025 /PRNewswire/ — TDK Corporation (TSE:6762) is presenting in its CES 2025 Booth #15815 how TDK MEMS sensors and solutions enable innovation in accessibility technology, as multi-award-winning company WeWALK announces global availability of its Smart Cane 2 for visually impaired people. The WeWALK Smart Cane 2 is an intelligent assistive device empowered by TDK motion sensors, MEMS microphones, and ultrasonic time-of-flight sensors, for highly accurate navigation, voice prompts, and obstacle avoidance.

WeWALK, whose recent accolades include The King’s Awards for Enterprise Innovation and Edison Awards 2024, will join the CES Consumer Technology Association’s (CTA) Accessibility roundtable on January 6, 2025 in Las Vegas and demonstrate its innovative Smart Cane 2 at the TDK CES booth #15815, January 7-10 and WeWALK CES booth #62035.

At the CTA Accessibility roundtable, WeWALK will unveil its groundbreaking Smart Cane 2, featuring an AI-powered voice assistant. During CES 2025, live demonstrations of this innovative cane will showcase its ability to enhance mobility and independence for visually impaired people, marking a significant leap forward in accessible technology.

The WeWALK Smart Cane 2 integrates multiple sensor solutions by InvenSense, a TDK group company, as well as TDK SMT inductors and RF antennae, showcasing the potential of TDK technology to enable a variety of IoT innovations. Also at the TDK booth, members of the visually impaired community can enter to receive one of eight WeWALK Smart Cane 2 devices, in a giveaway sponsored by TDK.*

“The new AI-powered WeWALK Smart Cane 2 combines insights from our own lived experiences and the visually impaired community with TDK’s expertise in advanced sensor technology,” said Kursat Ceylan, co-founder of WeWALK. “This collaboration has allowed us to redefine mobility and accessibility, creating a truly empowering tool for visually impaired individuals worldwide.”

TDK technology within the WeWALK Smart Cane 2 includes:

InvenSense SmartMotion® 6-axis IMU sensor, enabling Smart Cane 2 users to navigate both indoor and outdoor environments with the accuracy of an integrated gyroscope and accelerometerInvenSense SmartSound™ microphone sensor, offering an intelligent voice assistant to help Smart Cane 2 users explore wherever they want to goInvenSense SmartSonic™ ultrasonic time-of-flight sensor, for world-class presence detection and obstacle avoidance, to help ensure nothing gets in the way of safety and mobilityTDK multilayer chip antenna, to send and receive signals in the required frequencyTDK wound metal inductors for power circuitsTDK multilayer ferrite inductors for decoupling circuits 

“By using multiple TDK sensors to help create the intelligence of the Smart Cane 2, the WeWALK team shows the vast potential for sensor innovation,” said Massimo Mascotto, director of product marketing for InvenSense, a TDK group company. “We believe WeWALK inspires other engineers to use TDK sensors in creating products that improve lives.”

Learn more
For additional information about WeWALK and TDK products within the WeWALK Smart Cane 2, please visit invensense.tdk.com/wewalk.

About WeWALK
Founded in 2019, WeWALK is a UK-based startup with a mission to enhance the mobility of visually impaired people. It leverages cutting-edge technology and artificial intelligence to provide innovative solutions, such as the smart cane. WeWALK’s technologies enable blind and visually impaired people to enjoy greater mobility, safety, and independence. For more information, please visit https://wewalk.io. Images are available in the WeWALK press kit.

About the CES giveaway
*To enter TDK’s giveaway of the WeWALK’s new AI-powered Smart Cane 2, visit the TDK CES booth #15815 reception desk or WeWALK booth # 62035 and provide your contact information with a request to enter the Smart Cane 2 giveaway. Daily on January 7, 8, 9 and 10, TDK and WeWALK will randomly draw two entries and confirm winners by email; all eight winners will receive the Smart Cane 2 and associated training materials on the product’s estimated shipping date of February 2025.

Glossary

IMU: Inertial Measurement Unit6-axis: 3-axis gyroscope + 3-axis accelerometerMEMS: Micro-Electro-Mechanical Systems

Main applications for TDK MEMS sensors

Accessibility and medical devicesIoT and smart homeSmartphonesWearablesHearables / TWSAR/VR and gamingAction/dash camerasDronesNavigation modulesHome and industrial robotics

About TDK Corporation
TDK Corporation is a world leader in electronic solutions for the smart society based in Tokyo, Japan. Built on a foundation of material sciences mastery, TDK welcomes societal transformation by resolutely remaining at the forefront of technological evolution and deliberately “Attracting Tomorrow.” It was established in 1935 to commercialize ferrite, a key material in electronic and magnetic products. TDK’s comprehensive, innovation-driven portfolio features passive components such as ceramic, aluminum electrolytic and film capacitors, as well as magnetics, high-frequency, and piezo and protection devices. The product spectrum also includes sensors and sensor systems such as temperature and pressure, magnetic, and MEMS sensors. In addition, TDK provides power supplies and energy devices, magnetic heads and more. These products are marketed under the product brands TDK, EPCOS, InvenSense, Micronas, Tronics and TDK-Lambda. TDK focuses on demanding markets in automotive, industrial and consumer electronics, and information and communication technology. The company has a network of design and manufacturing locations and sales offices in Asia, Europe, and in North and South America. In fiscal 2024, TDK posted total sales of USD 14.6 billion and employed about 101,000 people worldwide.

About InvenSense
InvenSense, a TDK group company, is a world-leading provider of Sensing Solutions. InvenSense’s vision of Sensing Everything® targets the consumer electronics and industrial areas with integrated Motion, Sound, Pressure, and Ultrasonic solutions. InvenSense’s solutions combine MEMS (micro electrical mechanical systems) sensors, such as accelerometers, gyroscopes, compasses, microphones, barometric pressure sensors, and ultrasonic time-of-flight sensors with proprietary algorithms and firmware that intelligently process, synthesize, and calibrate the output of sensors, maximizing performance and accuracy. InvenSense’s motion tracking, ultrasonic, audio, fingerprint, location platforms and services can be found in Mobile, Wearables, Smart Home, Industrial, Automotive, IoT, Robotics, and many more types of products. InvenSense became part of the MEMS Sensors Business Group within the Sensor Systems Business Company of TDK Corporation in 2017. In April of 2022, Chirp Microsystems formally merged with InvenSense. InvenSense is headquartered in San Jose, California and has offices worldwide.

You can download this text and associated images from https://invensense.tdk.com/news-media/tdk-technologies-empower-accessibility-innovation-with-wewalks-ai-powered-smart-cane

Contacts for regional media

Photo – https://mma.prnewswire.com/media/2586360/TDK_WeWALK.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/tdk-technologies-empower-accessibility-innovation-with-wewalks-ai-powered-smart-cane-302337730.html

SOURCE TDK

This bisulfite-free method of methylation detection is updated with a faster, more streamlined workflow that enables highly sensitive methylation analysis with as little as 100 pg input.

IPSWICH, Mass., Jan. 6, 2025 /PRNewswire/ — New England Biolabs (NEB®) announces the launch of EM-seq™ v2, a high-performance enzyme-based alternative to bisulfite sequencing for the identification of 5mC and 5hmC. The enzyme-based conversion workflows for EM-seq and E5hmC-seq avoid the pitfalls of whole genome bisulfite treatment, including DNA damage that results in fragmentation, loss and bias. The newly updated kit delivers improved performance for wider input range (100 pg to 200 ng), and a faster, more streamlined workflow as compared to the original EM-seq kit.

“EM-seq v2 will be particularly valuable for researchers working in clinical research and epigenetics who often face challenges sequencing samples less than 10 ng that are below the input range of bisulfite sequencing and our original EM-seq kit,” says Andrew Barry, Associate Director of Product Portfolio Management for NEB’s sequencing product line. “The kit’s high-quality data from low input samples will enable researchers to get improved data for the same amount of sequencing, or similar data with less sequencing.”

Key improvements in EM-seq v2 include:

Substantially Lower DNA Input: The minimum input requirement has been reduced from 10 ng to 100 picograms, making EM-seq v2 suitable for applications with limited sample availability.Streamlined Workflow: EM-seq v2 features a faster incubation step and eliminates a cleanup step, resulting in a time savings of approximately 30-45 minutes.Improved Performance: The kit delivers enhanced data quality, with greater mapping efficiency, more even GC coverage and detection of more CpGs with fewer sequence reads.

“As an ISO 17025 accredited laboratory, we need reliable and reproducible kits and protocols,” says Dr. Marta Gut, Head of the Sequencing Unit at Centro Nacional de Análisis Genómico (CNAG) in Barcelona, Spain. “After thorough benchmarking of NEBNext Enzymatic Methyl-Seq v2 interrogating 5mC, the standard bisulfite conversion method lost its reference status for our methylation analyses. NEBNext EM-seq v2 and the NEBNext E5hmC-seq Kit for detecting 5hmC specifically, are now our methods of choice to study both modifications.”

EM-seq v2 is compatible with automation for easy scale-up and with 5hmC-seq for specific detection of 5hmC. Indexing primers are now supplied separately, providing greater flexibility for multiplexing samples. For further streamlining, enzymatic fragmentation of DNA compatible with EM-seq and E5hmC-seq workflows can be achieved using NEBNext UltraShear®.

The original EM-seq kit is not being discontinued at this time. More details and extensive performance data can be found at www.NEBNext.com

About New England Biolabs

For 50 years, New England Biolabs (NEB) has pioneered the discovery and production of innovative products tailored for molecular biology research. Our commitment to scientific discovery is evident in all that we do, including our ever-expanding product portfolio, investment in our basic and applied research program, and support of customers’ research in academia and industry, including cutting-edge technologies for use in molecular diagnostics and nucleic-acid vaccines development. Guided by our founding principles, NEB proactively invests in efforts to improve the well-being of our employees, surrounding communities, as well as the future of our planet. NEB remains a privately held company with global reach, supported by our headquarters in Ipswich, MA, USA, subsidiary offices in 10 countries, and over 60 distribution partners around the world. For more information about New England Biolabs, visit www.neb.com.

NEB®, NEW ENGLAND BIOLABS® and NEBNEXT ULTRASHEAR® are registered trademarks of New England Biolabs, Inc.
EM-Seq™ is a trademark of New England Biolabs, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-england-biolabs-launches-em-seq-v2-an-updated-kit-for-more-sensitive-detection-of-5mc-and-5hmc-302338317.html

SOURCE New England Biolabs, Inc.